Yuesong Pan Selected Research

Yuesong Pan Research Topics

Disease

111	Stroke (Strokes) 11/2022 - 01/2013
93	Ischemic Stroke 11/2022 - 01/2014
38	Transient Ischemic Attack 11/2022 - 06/2014
16	Hemorrhage 01/2022 - 07/2015
11	Diabetes Mellitus 12/2021 - 08/2013
10	Insulin Resistance 01/2022 - 01/2017
8	Prediabetic State (Prediabetes) 08/2022 - 09/2014
7	Atrial Fibrillation 01/2022 - 05/2013
7	Pathologic Constriction (Stenosis) 01/2021 - 01/2013
5	Cardiovascular Diseases (Cardiovascular Disease) 11/2022 - 01/2017
5	Cognitive Dysfunction 02/2022 - 01/2021
5	Chronic Renal Insufficiency 01/2022 - 01/2018
5	Atherosclerosis 01/2022 - 08/2018
5	Hyperglycemia 01/2020 - 11/2017
5	Cerebral Hemorrhage 01/2019 - 10/2015
4	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2021 - 03/2015
4	Type 2 Diabetes Mellitus (MODY) 11/2020 - 01/2018
3	Cerebral Small Vessel Diseases 11/2022 - 01/2014
3	Inflammation (Inflammations) 11/2022 - 01/2019
3	Hypertension (High Blood Pressure) 01/2022 - 01/2019
3	Infarction (Infarctions) 01/2021 - 01/2018
2	Pain (Aches) 01/2021 - 01/2018
2	Alzheimer Disease (Alzheimer's Disease) 11/2020 - 12/2019
2	Thrombosis (Thrombus) 05/2020 - 04/2019
2	Myocardial Infarction 05/2020 - 04/2019
2	Brain Ischemia (Cerebral Ischemia) 02/2019 - 08/2013
2	Intracranial Arteriosclerosis (Cerebral Atherosclerosis) 08/2018 - 06/2016
2	Hematoma 07/2018 - 11/2013
2	Deglutition Disorders (Dysphagia) 01/2017 - 05/2013
2	Heart Failure 02/2016 - 05/2013
2	Leukoaraiosis 11/2014 - 01/2014
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 10/2022
1	Glucose Intolerance 08/2022
1	Body Weight (Weight, Body) 01/2022
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022
1	Coronary Disease (Coronary Heart Disease) 01/2022
1	Albuminuria 01/2022
1	Noncommunicable Diseases 08/2021
1	Postoperative Pain 01/2021
1	Cerebral Infarction 01/2021
1	Glioblastoma (Glioblastoma Multiforme) 01/2021

Drug/Important Bio-Agent (IBA)

31	Clopidogrel (Plavix)FDA Link 11/2022 - 06/2014
26	Glucose (Dextrose)FDA LinkGeneric 08/2022 - 09/2014
24	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2022 - 06/2014
12	Cytochrome P-450 CYP2C19IBA 11/2022 - 07/2016
12	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2022 - 01/2014
10	TicagrelorIBA 01/2022 - 01/2017
8	C-Reactive ProteinIBA 11/2022 - 01/2013
8	Biomarkers (Surrogate Marker)IBA 06/2022 - 01/2019
7	Indicators and Reagents (Reagents)IBA 11/2022 - 01/2014
7	Blood Glucose (Blood Sugar)IBA 01/2020 - 05/2013
6	Insulin (Novolin)FDA Link 01/2022 - 01/2018
6	danaparoid (Orgaran)FDA Link 01/2022 - 01/2016
6	Triglycerides (Triacylglycerol)IBA 01/2022 - 11/2015
6	Hemoglobins (Hemoglobin)IBA 11/2020 - 01/2016
4	oxidized low density lipoproteinIBA 11/2022 - 01/2021
4	LDL CholesterolIBA 11/2022 - 01/2021
4	AlbuminsIBA 01/2022 - 11/2017
3	Interleukin-6 (Interleukin 6)IBA 06/2022 - 01/2021
3	CholesterolIBA 01/2022 - 12/2020
3	Cystatin CIBA 01/2022 - 01/2021
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 11/2014
3	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2020 - 09/2014
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 10/2022 - 01/2019
2	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 06/2022 - 02/2020
2	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 06/2022 - 02/2020
2	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2022 - 01/2021
2	CreatinineIBA 01/2022 - 01/2022
2	LipidsIBA 01/2022 - 01/2019
2	Tenecteplase FDA Link 01/2022 - 01/2022
2	HomocysteineIBA 12/2021 - 07/2018
2	Lipoprotein(a)IBA 01/2021 - 12/2019
2	AnticoagulantsIBA 01/2021 - 01/2019
2	Antihypertensive Agents (Antihypertensives)IBA 01/2021 - 01/2021
2	Uric Acid (Urate)IBA 01/2021 - 02/2017
2	Nonesterified Fatty Acids (NEFA)IBA 01/2020 - 01/2020
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 10/2022
1	indobufenIBA 10/2022
1	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 06/2022
1	TransferasesIBA 02/2022
1	HDL CholesterolIBA 12/2021
1	Ropivacaine (Naropin)FDA LinkGeneric 01/2021
1	Choline (Choline Chloride)IBA 01/2021
1	Tirofiban (Aggrastat)FDA Link 01/2021
1	Peptide Hydrolases (Proteases)FDA Link 01/2021
1	Adenosine Diphosphate (ADP)IBA 01/2021
1	Phosphates (Orthophosphate)IBA 01/2021
1	CalciumIBA 01/2021
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2021
1	fibrin fragment D (D-dimer)IBA 01/2021
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021

Therapy/Procedure

35	Therapeutics 11/2022 - 01/2013
14	Secondary Prevention 07/2022 - 06/2017
7	Thrombectomy 01/2021 - 06/2016
5	Stents 05/2020 - 08/2018
3	Length of Stay 01/2017 - 03/2014
2	Punctures 01/2021 - 01/2021
2	Glycemic Control 01/2019 - 01/2018
1	Local Anesthesia 01/2021
1	Conservative Treatment 01/2021